| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Detection of circulating tumor DNA in early- and late-stage human malignancies.
|
Sci Transl Med
|
2014
|
8.36
|
|
2
|
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
|
Lancet
|
2015
|
7.99
|
|
3
|
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
|
Sci Transl Med
|
2011
|
5.03
|
|
4
|
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
|
Proc Natl Acad Sci U S A
|
2011
|
3.51
|
|
5
|
Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection.
|
J Am Coll Surg
|
2010
|
2.98
|
|
6
|
Feasibility and yield of screening in relatives from familial pancreatic cancer families.
|
Am J Gastroenterol
|
2011
|
2.42
|
|
7
|
Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution.
|
Ann Surg
|
2013
|
2.29
|
|
8
|
Pancreatic adenocarcinoma: the actual 5-year survivors.
|
J Gastrointest Surg
|
2007
|
2.22
|
|
9
|
Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system.
|
J Am Coll Surg
|
2007
|
2.12
|
|
10
|
Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study.
|
Ann Surg Oncol
|
2009
|
2.10
|
|
11
|
Impact of steatosis on perioperative outcome following hepatic resection.
|
J Gastrointest Surg
|
2003
|
2.05
|
|
12
|
Serum biomarker panels for the detection of pancreatic cancer.
|
Clin Cancer Res
|
2011
|
1.98
|
|
13
|
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.
|
J Am Coll Surg
|
2010
|
1.98
|
|
14
|
Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
|
Hepatology
|
2012
|
1.94
|
|
15
|
Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer.
|
J Gastrointest Surg
|
2007
|
1.86
|
|
16
|
Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.
|
Ann Surg Oncol
|
2011
|
1.75
|
|
17
|
Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
|
J Am Coll Surg
|
2012
|
1.71
|
|
18
|
Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.
|
Ann Surg
|
2015
|
1.64
|
|
19
|
Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?
|
J Clin Oncol
|
2007
|
1.64
|
|
20
|
Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011.
|
J Am Coll Surg
|
2012
|
1.58
|
|
21
|
Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases.
|
JAMA Surg
|
2013
|
1.58
|
|
22
|
Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
|
Ann Surg
|
2011
|
1.57
|
|
23
|
Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution.
|
J Gastrointest Surg
|
2007
|
1.47
|
|
24
|
Laparoscopic distal pancreatectomy: evolution of a technique at a single institution.
|
J Am Coll Surg
|
2010
|
1.46
|
|
25
|
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.
|
Oncologist
|
2011
|
1.44
|
|
26
|
Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
|
Ann Surg
|
2010
|
1.43
|
|
27
|
Changes in the management of benign liver tumours: an analysis of 285 patients.
|
HPB (Oxford)
|
2012
|
1.42
|
|
28
|
Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period.
|
J Am Coll Surg
|
2011
|
1.41
|
|
29
|
Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway.
|
Genes Cancer
|
2010
|
1.38
|
|
30
|
Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality.
|
Ann Surg Oncol
|
2010
|
1.37
|
|
31
|
BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.
|
J Clin Oncol
|
2008
|
1.36
|
|
32
|
Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005.
|
J Am Coll Surg
|
2008
|
1.36
|
|
33
|
Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center.
|
J Gastrointest Surg
|
2010
|
1.33
|
|
34
|
Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma.
|
Ann Surg Oncol
|
2008
|
1.31
|
|
35
|
Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries.
|
J Am Coll Surg
|
2010
|
1.31
|
|
36
|
Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management.
|
Ann Surg
|
2010
|
1.28
|
|
37
|
PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue.
|
ACS Nano
|
2008
|
1.25
|
|
38
|
Allergies, obesity, other risk factors and survival from pancreatic cancer.
|
Int J Cancer
|
2010
|
1.23
|
|
39
|
Laparoscopic versus open liver resection: a matched-pair case control study.
|
J Gastrointest Surg
|
2009
|
1.23
|
|
40
|
The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients.
|
J Am Coll Surg
|
2012
|
1.23
|
|
41
|
Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy.
|
Oncologist
|
2011
|
1.20
|
|
42
|
Resection of adrenocortical carcinoma liver metastasis: is it justified?
|
Ann Surg Oncol
|
2012
|
1.18
|
|
43
|
Single-incision laparoscopic liver resection.
|
Surg Endosc
|
2010
|
1.18
|
|
44
|
Liberal resection for (presumed) Sendai negative branch-duct intraductal papillary mucinous neoplasms--also not harmless.
|
Ann Surg
|
2014
|
1.17
|
|
45
|
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.
|
PLoS One
|
2012
|
1.15
|
|
46
|
Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation.
|
Ann Surg Oncol
|
2012
|
1.14
|
|
47
|
Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
|
Ann Surg Oncol
|
2010
|
1.13
|
|
48
|
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract.
|
J Exp Clin Cancer Res
|
2009
|
1.12
|
|
49
|
Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
|
Clin Cancer Res
|
2011
|
1.11
|
|
50
|
Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.
|
Ann Surg Oncol
|
2011
|
1.10
|
|
51
|
Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas.
|
J Gastrointest Surg
|
2010
|
1.10
|
|
52
|
Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma.
|
Ann Surg
|
2011
|
1.07
|
|
53
|
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
|
J Gastrointest Surg
|
2014
|
1.06
|
|
54
|
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
|
Ann Surg
|
2015
|
1.06
|
|
55
|
A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified.
|
J Gastrointest Surg
|
2009
|
1.04
|
|
56
|
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
|
Ann Surg Oncol
|
2009
|
1.04
|
|
57
|
Studying cancer in minorities: a look at the numbers.
|
Cancer
|
2011
|
1.04
|
|
58
|
Five hundred patients with Merkel cell carcinoma evaluated at a single institution.
|
Ann Surg
|
2011
|
1.04
|
|
59
|
KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.
|
Cancer
|
2014
|
1.02
|
|
60
|
Internal hernia after gastrectomy for cancer with Roux-Y reconstruction.
|
Surgery
|
2013
|
1.00
|
|
61
|
Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation.
|
HPB (Oxford)
|
2012
|
1.00
|
|
62
|
Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
|
Ann Surg Oncol
|
2012
|
0.99
|
|
63
|
Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
|
Ann Surg Oncol
|
2012
|
0.98
|
|
64
|
The role of laparoscopic staging in patients with incidental gallbladder cancer.
|
HPB (Oxford)
|
2011
|
0.96
|
|
65
|
A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases.
|
Ann Surg Oncol
|
2014
|
0.96
|
|
66
|
Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.
|
Ann Surg Oncol
|
2014
|
0.96
|
|
67
|
Is port site resection necessary in the surgical management of gallbladder cancer?
|
Ann Surg Oncol
|
2011
|
0.96
|
|
68
|
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
|
J Am Coll Surg
|
2012
|
0.96
|
|
69
|
Pancreas and liver resection in Jehovah's Witness patients: feasible and safe.
|
J Am Coll Surg
|
2013
|
0.96
|
|
70
|
Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma.
|
Cancer
|
2011
|
0.95
|
|
71
|
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
|
J Gastrointest Surg
|
2006
|
0.95
|
|
72
|
Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6.
|
Clin Cancer Res
|
2012
|
0.94
|
|
73
|
The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.
|
J Gastrointest Surg
|
2006
|
0.94
|
|
74
|
Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer.
|
J Am Coll Surg
|
2009
|
0.94
|
|
75
|
Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.
|
Ann Surg Oncol
|
2013
|
0.93
|
|
76
|
CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
|
Ann Surg Oncol
|
2011
|
0.93
|
|
77
|
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.
|
Ann Surg
|
2014
|
0.92
|
|
78
|
Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases.
|
HPB (Oxford)
|
2014
|
0.90
|
|
79
|
Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.
|
Ann Surg Oncol
|
2007
|
0.88
|
|
80
|
Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.
|
Ann Surg Oncol
|
2012
|
0.88
|
|
81
|
Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma.
|
Ann Surg
|
2002
|
0.87
|
|
82
|
Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence.
|
Ann Surg Oncol
|
2012
|
0.87
|
|
83
|
Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
|
Surgery
|
2011
|
0.87
|
|
84
|
Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis.
|
HPB (Oxford)
|
2013
|
0.87
|
|
85
|
T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.
|
HPB (Oxford)
|
2010
|
0.87
|
|
86
|
High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy.
|
HPB (Oxford)
|
2011
|
0.86
|
|
87
|
Readmission after pancreatic resection: causes and causality pattern.
|
Ann Surg Oncol
|
2014
|
0.86
|
|
88
|
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.
|
Ann Surg Oncol
|
2011
|
0.86
|
|
89
|
Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas.
|
World J Gastrointest Surg
|
2010
|
0.86
|
|
90
|
Defining surgical indications for type I gastric carcinoid tumor.
|
Ann Surg Oncol
|
2009
|
0.86
|
|
91
|
Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy.
|
World J Gastrointest Surg
|
2010
|
0.86
|
|
92
|
American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions.
|
HPB (Oxford)
|
2014
|
0.85
|
|
93
|
Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression.
|
Ann Surg
|
2013
|
0.85
|
|
94
|
Synchronous resection of primary and liver metastases for neuroendocrine tumors.
|
Ann Surg Oncol
|
2012
|
0.85
|
|
95
|
Predicting recurrence patterns after resection of hepatocellular cancer.
|
HPB (Oxford)
|
2014
|
0.84
|
|
96
|
Pancreatic metastasectomy: the Memorial Sloan-Kettering experience and a review of the literature.
|
J Surg Oncol
|
2013
|
0.84
|
|
97
|
Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis.
|
HPB (Oxford)
|
2013
|
0.84
|
|
98
|
Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential.
|
J Gastrointest Surg
|
2014
|
0.83
|
|
99
|
Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al.
|
Ann Surg Oncol
|
2009
|
0.83
|
|
100
|
Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy.
|
Am J Gastroenterol
|
2013
|
0.83
|
|
101
|
Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
|
Ann Surg Oncol
|
2013
|
0.83
|
|
102
|
Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging.
|
AJR Am J Roentgenol
|
2013
|
0.83
|
|
103
|
The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis.
|
Surgery
|
2011
|
0.82
|
|
104
|
Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
|
Ann Surg Oncol
|
2013
|
0.82
|
|
105
|
Colon sentinel lymph node mapping: practical surgical applications.
|
J Am Coll Surg
|
2005
|
0.82
|
|
106
|
Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis.
|
Ann Surg Oncol
|
2012
|
0.82
|
|
107
|
Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms.
|
HPB (Oxford)
|
2013
|
0.82
|
|
108
|
Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.
|
Ann Surg
|
2016
|
0.82
|
|
109
|
Synthesis, characterization, and functionalization of gold nanoparticles for cancer imaging.
|
Methods Mol Biol
|
2010
|
0.81
|
|
110
|
Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days?
|
HPB (Oxford)
|
2012
|
0.81
|
|
111
|
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer.
|
Cancer
|
2012
|
0.80
|
|
112
|
Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease.
|
Ann Surg
|
2015
|
0.80
|
|
113
|
Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver.
|
Cardiovasc Intervent Radiol
|
2009
|
0.79
|
|
114
|
Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases.
|
J Gastrointest Surg
|
2011
|
0.79
|
|
115
|
Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?
|
Ann Surg Oncol
|
2013
|
0.79
|
|
116
|
Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
|
Ann Surg
|
2016
|
0.79
|
|
117
|
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection.
|
Ann Surg Oncol
|
2015
|
0.79
|
|
118
|
Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer.
|
Pancreas
|
2016
|
0.78
|
|
119
|
Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy.
|
J Gastrointest Surg
|
2013
|
0.78
|
|
120
|
Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
|
AJR Am J Roentgenol
|
2014
|
0.78
|
|
121
|
Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single center.
|
Surgery
|
2011
|
0.78
|
|
122
|
Clinical features and outcome of primary pancreatic lymphoma.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
123
|
Initial report of laparoscopic celiac plexus block for pain relief in patients with unresectable pancreatic cancer.
|
J Am Coll Surg
|
2006
|
0.77
|
|
124
|
Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
|
Ann Surg
|
2017
|
0.77
|
|
125
|
Management of peripancreatic fluid collections following partial pancreatectomy: a comparison of percutaneous versus EUS-guided drainage.
|
Surg Endosc
|
2013
|
0.76
|
|
126
|
Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
|
Ann Surg Oncol
|
2013
|
0.76
|
|
127
|
Impact of pre-operative positron emission tomography in gallbladder cancer.
|
HPB (Oxford)
|
2014
|
0.76
|
|
128
|
The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial.
|
Ann Surg
|
2016
|
0.75
|
|
129
|
Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy.
|
HPB (Oxford)
|
2013
|
0.75
|
|
130
|
Reply to Letter: "Operative Drainage Following Pancreatic Resections: We Need More Evidence".
|
Ann Surg
|
2015
|
0.75
|
|
131
|
Metastatic carcinoid tumour presenting as hepatic encephalopathy.
|
HPB (Oxford)
|
2002
|
0.75
|
|
132
|
Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy.
|
Ann Surg
|
2016
|
0.75
|
|
133
|
Pasireotide for postoperative pancreatic fistula.
|
N Engl J Med
|
2014
|
0.75
|
|
134
|
Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution.
|
Ann Surg
|
2017
|
0.75
|
|
135
|
Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
|
Ann Surg
|
2016
|
0.75
|
|
136
|
Randomized clinical trials in pancreatic adenocarcinoma.
|
Surg Oncol Clin N Am
|
2010
|
0.75
|
|
137
|
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.
|
Pancreas
|
2017
|
0.75
|
|
138
|
Pitfalls in avoiding operation for autoimmune pancreatitis.
|
Surgery
|
2011
|
0.75
|
|
139
|
Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
|
Ann Surg
|
2017
|
0.75
|
|
140
|
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.
|
Ann Surg
|
2017
|
0.75
|
|
141
|
Significance of pathologic response to preoperative therapy in pancreatic cancer: the future ain't what it used to be.
|
Ann Surg Oncol
|
2011
|
0.75
|
|
142
|
Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease.
|
J Surg Oncol
|
2012
|
0.75
|
|
143
|
Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence.
|
Clin Colorectal Cancer
|
2011
|
0.75
|
|
144
|
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.
|
Pancreas
|
2016
|
0.75
|
|
145
|
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.
|
Pancreas
|
2017
|
0.75
|